Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Imidazoles. Found 6 abstracts

Dasgupta Y, Koptyra M, Hoser G, Kantekure K, Roy D, Gornicka B, Nieborowska-Skorska M, Bolton-Gillespie E, Cerny-Reiterer S, Muschen M, Valent P, Wasik MA, Richardson C, Hantschel O, van der Kuip H, Stoklosa T, Skorski T. Normal ABL1 is a tumor suppressor and therapeutic target in human and mouse leukemias expressing oncogenic ABL1 kinases. Blood. 2016 Apr 28;127(17):2131-43.   PMCID: PMC4850868
Najjar M, Suebsuwong C, Ray S, Thapa R, Maki J, Nogusa S, Shah S, Saleh D, Gough P, Bertin J, Yuan J, Balachandran S, Cuny G, Degterev A. Structure guided design of potent and selective ponatinib-based hybrid inhibitors for RIPK1. Cell Reports. 2015 Mar 24;10(11):1850-60.   PMCID: 4494889
Twelves C, Chmielowska E, Havel L, Popat S, Swieboda-Sadlej A, Sawrycki P, Bycott P, Ingrosso A, Kim S, Williams JA, Chen C, Olszanski AJ, de Besi P, Schiller JH. Randomised phase II study of axitinib or bevacizumab combined with paclitaxel/carboplatin as first-line therapy for patients with advanced non-small-cell lung cancer. Ann Oncol. 2014 Jan;25(1):132-8.   PMCID: No NIH funds
Ding PR, Tiwari AK, Ohnuma S, Lee JW, An X, Dai CL, Lu QS, Singh S, Yang DH, Talele TT, Ambudkar SV, Chen ZS. The phosphodiesterase-5 inhibitor vardenafil is a potent inhibitor of ABCB1/P-glycoprotein transporter. PLoS One. 2011 Jan;6(4):e19329.   PMCID: PMC3084276
Langer CJ. Role of zoledronic acid in the setting of bone metastases from non-small-cell lung cancer. Clinical lung cancer. 2005 Jan;6(5):314-6, 2005 Mar.
Shastry MC, Roder H. Evidence for barrier-limited protein folding kinetics on the microsecond time scale. Nat Struct Biol. 1998 May;5(5):385-92.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Imidazoles

Imidazoles pharmacology Female chemistry antagonists & inhibitors therapeutic use Antineoplastic Combined Chemotherapy Protocols Mice drug therapy Molecular Models pathology Lung Neoplasms metabolism Antineoplastic Agents Middle Aged drug effects Pyridazines Protein Kinase Inhibitors Oxidative Stress 0 (Imidazoles) Proportional Hazards Models 118072-93-8 (zoledronic acid) sc [Secondary] Cytostatic Agents Imatinib Mesylate Substrate Specificity Tumor Cell Line Fusion Oncogene Proteins chemotherapy Temperature Leukemic Gene Expression Regulation et [Etiology] Paclitaxel pa [Pathology] Secondary Hypertrophic Osteoarthropathy Inbred NOD Mice 0 (Diphosphonates) genetics Receptor-Interacting Protein Serine-Threonine Kinases Energy Metabolism Treatment Outcome dt [Drug Therapy] Horses Diphosphonates Triazines Jurkat Cells Amino Acid Sequence Oncogene Proteins v-abl Monoclonal Antibodies-Humanized Brain Neoplasms methods Indazoles Cytochrome c Myeloid Leukemia-Chronic-Phase Inbred C57BL Mice Neoplastic Gene Expression Regulation Molecular Sequence Data US Gov't Support-PHS Bevacizumab Animal Male HEK293 Cells Cell Division co [Complications] tu [Therapeutic adverse effects Sulfones non-squamous Ligands US Gov't Support-Non-PHS abl Genes Neoplasm Drug Resistance Protein Folding Kaplan-Meier Estimate Fluorescence Spectrometry Apoptosis Neutropenia non-small-cell lung cancer bevacizumab Bone Neoplasms Tumor Suppressor Genes Genomic Instability SCID Mice instrumentation antagonists & 0 (Antineoplastic Combined Chemotherapy Protocols) Carboplatin Neoplastic Stem Cells Non-US Gov't Support Protein Conformation Proto-Oncogene Proteins c-abl chemically induced Carbolines Experimental Leukemia enzymology Molecular Docking Simulation Protein Binding Type 5 Cyclic Nucleotide Phosphodiesterases physiology Squamous Cell Carcinoma th [Therapy] Tumor Suppressor Proteins inhibitors Neoplasm Proteins Disease Progression Blast Crisis KB Cells Phosphodiesterase 5 Inhibitors Heme Adenosine Triphosphatases Disease-Free Survival Aged Axitinib Neoplasm Staging P-Glycoprotein mortality axitinib administration & dosage Use] Non-Small-Cell Lung Carcinoma tu [Therapeutic Use] Kinetics Piperazines
Last updated on Wednesday, February 05, 2020